Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 57,584 | 49,504 | 39,503 | 28,519 | 29,664 |
| Cost of Goods | 7,647 | 6,190 | 5,038 | 3,724 | 3,815 |
| Gross Profit | 49,937 | 43,314 | 34,465 | 24,795 | 25,849 |
| Operating Expenses | 56,512 | 58,775 | 94,427 | 104,382 | 86,081 |
| Operating Income | -5,928 | -15,271 | -59,924 | -78,863 | -59,417 |
| Interest Expense | 16,418 | 16,108 | 17,518 | 18,071 | 18,593 |
| Other Income | 1,198 | 1,406 | 1,632 | 2,618 | 3,559 |
| Pre-tax Income | -21,148 | -29,973 | -75,810 | -94,316 | -74,451 |
| Net Income Continuous | -21,148 | -29,973 | -75,810 | -94,316 | -74,451 |
| Net Income | $-21,148 | $-29,973 | $-75,810 | $-94,316 | $-74,451 |
| EPS Basic Total Ops | -0.26 | -0.41 | -1.05 | -1.31 | -0.99 |
| EPS Basic Continuous Ops | -0.27 | -0.41 | -1.05 | -1.31 | -0.99 |
| EPS Diluted Total Ops | -0.26 | -0.41 | -1.05 | -1.31 | -0.99 |
| EPS Diluted Continuous Ops | -0.27 | -0.41 | -1.05 | -1.31 | -0.99 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.28 | -0.90 | -1.15 | -0.88 |
| EBITDA(a) | $-4,991 | $-14,340 | $-59,018 | $-77,990 | $-58,595 |